CSPC Innovation Pharmaceutical Co (300765.SZ) Stock Price
CSPC Innovation Pharmaceutical Co Price
Over the last 11 years CSPC Innovation Pharmaceutical Co grew revenue by 11.5% annually, reaching 2.15 B CNY. Earnings per share have declined at 6.8% per year over the last 10 years. For CSPC Innovation Pharmaceutical Co, the net margin of -11.2% is down versus 21.3% a few years ago. At today's price the dividend yield works out to roughly 0.06%. The consensus 12-month price target for CSPC Innovation Pharmaceutical Co is 57.83 CNY, about 68.3% above where the stock trades today. Of 7 analysts, 5 rate the stock a buy — an overall Buy consensus.
CSPC Innovation Pharmaceutical Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
CSPC Innovation Pharmaceutical Co business model & stock analysis
Frequently asked questions about CSPC Innovation Pharmaceutical Co
Analysts currently set an average price target of 57.83 CNY for the CSPC Innovation Pharmaceutical Co stock (median: 57.83 CNY), implying +77.0 % versus the latest price. The consensus is based on 7 analyst ratings.
CSPC Innovation Pharmaceutical Co Analyst Price Targets 2026
7 analysts currently rate the CSPC Innovation Pharmaceutical Co stock: 5 recommend buying, 2 holding and 0 selling. For 2026, analysts expect CSPC Innovation Pharmaceutical Co to generate revenue of 4.90 B CNY and earnings per share of 0.86 CNY.
CSPC Innovation Pharmaceutical Co Analyst Price Targets 2026
Converted at the current exchange rate, the CSPC Innovation Pharmaceutical Co share trades at 4.68 EUR (34.36 CNY).
The CSPC Innovation Pharmaceutical Co share (300765.SZ) is listed on 1 stock exchanges, including: Shenzhen (300765.SZ).
The expected revenue of CSPC Innovation Pharmaceutical Co is 4.90 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of CSPC Innovation Pharmaceutical Co is 1.19 B CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of CSPC Innovation Pharmaceutical Co is currently 40.09. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the CSPC Innovation Pharmaceutical Co stock.
The price-to-sales ratio (P/S) of CSPC Innovation Pharmaceutical Co is currently 9.77. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the CSPC Innovation Pharmaceutical Co stock.
The Eulerpool Quality Score for CSPC Innovation Pharmaceutical Co is 4/10.
The ISIN of CSPC Innovation Pharmaceutical Co is CNE100003K04. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of CSPC Innovation Pharmaceutical Co is 300765.SZ. The ticker symbol is used to trade CSPC Innovation Pharmaceutical Co shares on the stock exchange.
CSPC Innovation Pharmaceutical Co stock
CSPC Innovation Pharmaceutical Co Peer Group
CSPC Innovation Pharmaceutical Co Ticker
CSPC Innovation Pharmaceutical Co FIGI
All fundamentals and in-depth analysis of CSPC Innovation Pharmaceutical Co
Our stock analysis for CSPC Innovation Pharmaceutical Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CSPC Innovation Pharmaceutical Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.